NGN Capital is an institutional investor (Conventional VCs) founded in 2003 and headquartered in Stamford, United States. Venture capital firm investing in innovative healthcare and life sciences companies. The firm focuses on providing financial resources and strategic support to companies with the potential to significantly impact the healthcare landscape. They actively seek opportunities in areas such as biotechnology, pharmaceuticals, medical devices, and diagnostics. The team brings extensive industry knowledge and operational expertise to help portfolio companies achieve their goals. They aim to foster growth and innovation within the healthcare sector, ultimately improving patient outcomes and driving advancements in medical technology. The firm's investment approach is centered on identifying promising ventures and partnering with talented entrepreneurs to build successful and sustainable businesses.

Stage

early-stage, Series A, Series B, Series D, pre-IPO, growth-stage, PIPE, LBO, early-stage, Series A, Series B, Series D, pre-IPO, growth-stage, PIPE, LBO

Check size

$7M-$40M

HQ

Heidelberg, Germany

Founded

2003

Website

https://www.ngncapital.com/

LinkedIn

https://linkedin.com/company/ngn-capital/about

Twitter

https://twitter.com/swiperxapp_ph

What they look for

primarily US and Europe geography; late-stage emphasis with select early-stage; potential for above-average private equity returns

Preparing to pitch NGN Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.